Clinical trial
A Study of Vinflunine in Patients With Gastric Cancer
NCT00359476 · Bristol-Myers Squibb, Industry · Terminated
Key facts
| NCT number | NCT00359476 |
|---|---|
| Title | A Study of Vinflunine in Patients With Gastric Cancer |
| Official title | A Multicenter, Single-Arm, Phase II Study of Single-Agent Vinflunine in the Second-line Treatment of Patients With Gastric Cancer |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Stomach Cancer |
| Intervention type | Drug |
| Interventions | Vinflunine |
| Enrollment | 55 |
| Start date | Mar 1, 2007 |
| Primary completion | Oct 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Aug 2, 2006 |
| Last update posted | Mar 2, 2010 |
| Countries | Malaysia, Philippines, South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: